Ghost Tree Capital as of Sept. 30, 2021
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 58 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf Call Option (IWM) | 6.4 | $22M | 100k | 218.75 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 5.6 | $19M | 120k | 159.39 | |
| Iovance Biotherapeutics (IOVA) | 5.0 | $17M | 700k | 24.66 | |
| Xenon Pharmaceuticals (XENE) | 4.6 | $16M | 1.0M | 15.28 | |
| Celldex Therapeutics Com New (CLDX) | 4.0 | $14M | 255k | 53.99 | |
| Cogent Biosciences (COGT) | 3.7 | $13M | 1.5M | 8.41 | |
| Arvinas Ord (ARVN) | 3.6 | $12M | 150k | 82.18 | |
| Iveric Bio | 3.4 | $12M | 725k | 16.24 | |
| Apellis Pharmaceuticals (APLS) | 3.4 | $12M | 350k | 32.96 | |
| Syndax Pharmaceuticals (SNDX) | 3.2 | $11M | 575k | 19.11 | |
| Mirati Therapeutics | 3.1 | $11M | 60k | 176.92 | |
| Rocket Pharmaceuticals (RCKT) | 3.1 | $11M | 350k | 29.89 | |
| Allakos (ALLK) | 2.6 | $9.0M | 85k | 105.87 | |
| Gh Research Ordinary Shares (GHRS) | 2.6 | $8.8M | 400k | 22.06 | |
| Kura Oncology (KURA) | 2.3 | $8.0M | 425k | 18.73 | |
| Rapt Therapeutics (RAPT) | 2.3 | $7.8M | 250k | 31.05 | |
| Leap Therapeutics | 1.9 | $6.6M | 1.7M | 4.01 | |
| Beyondspring SHS Call Option (BYSI) | 1.8 | $6.3M | 400k | 15.76 | |
| Aldeyra Therapeutics (ALDX) | 1.8 | $6.1M | 700k | 8.78 | |
| Miragen Therapeutics (VRDN) | 1.7 | $5.8M | 350k | 16.45 | |
| Vistagen Therapeutics Com New | 1.6 | $5.5M | 2.0M | 2.74 | |
| Atea Pharmaceuticals (AVIR) | 1.5 | $5.3M | 150k | 35.06 | |
| Relmada Therapeutics (RLMD) | 1.5 | $5.2M | 200k | 26.21 | |
| Aclaris Therapeutics (ACRS) | 1.4 | $5.0M | 275k | 18.00 | |
| Helix Acquisition Corp Com Cl A | 1.4 | $4.9M | 500k | 9.89 | |
| Cti Biopharma | 1.4 | $4.7M | 1.6M | 2.95 | |
| Praxis Precision Medicines I | 1.4 | $4.6M | 250k | 18.49 | |
| Sierra Oncology Com New | 1.3 | $4.4M | 200k | 21.92 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.3 | $4.3M | 65k | 66.65 | |
| Satsuma Pharmaceuticals Ord | 1.2 | $4.2M | 904k | 4.66 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.2 | $4.2M | 100k | 41.59 | |
| Catalyst Biosciences Com New | 1.2 | $4.1M | 1.0M | 4.11 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.2 | $4.1M | 750k | 5.48 | |
| Tcr2 Therapeutics Inc cs | 1.2 | $4.1M | 477k | 8.51 | |
| Vaxcyte (PCVX) | 1.2 | $4.1M | 160k | 25.37 | |
| Allogene Therapeutics (ALLO) | 1.1 | $3.9M | 150k | 25.70 | |
| Tarsus Pharmaceuticals (TARS) | 1.1 | $3.7M | 170k | 21.55 | |
| 9 Meters Biopharma | 1.0 | $3.6M | 2.8M | 1.30 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.9 | $3.2M | 150k | 21.05 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.9 | $3.0M | 100k | 29.87 | |
| Fate Therapeutics (FATE) | 0.9 | $3.0M | 50k | 59.28 | |
| Harmony Biosciences Hldgs In (HRMY) | 0.8 | $2.9M | 75k | 38.33 | |
| Amicus Therapeutics (FOLD) | 0.7 | $2.5M | 265k | 9.55 | |
| Bellus Health Com New | 0.7 | $2.5M | 400k | 6.14 | |
| Immunic (IMUX) | 0.7 | $2.3M | 265k | 8.85 | |
| Larimar Therapeutics (LRMR) | 0.7 | $2.3M | 200k | 11.53 | |
| Moderna (MRNA) | 0.6 | $2.0M | 5.3k | 384.91 | |
| Alector (ALEC) | 0.5 | $1.8M | 80k | 22.82 | |
| Immunovant Call Option (IMVT) | 0.5 | $1.7M | 200k | 8.69 | |
| Merus N V (MRUS) | 0.5 | $1.7M | 75k | 22.00 | |
| Fulcrum Therapeutics (FULC) | 0.4 | $1.4M | 50k | 28.22 | |
| Chimerix (CMRX) | 0.4 | $1.2M | 200k | 6.19 | |
| Cabaletta Bio (CABA) | 0.4 | $1.2M | 100k | 12.16 | |
| Otonomy | 0.3 | $864k | 450k | 1.92 | |
| Casi Pharmaceuticalsinc Com Stk | 0.2 | $774k | 650k | 1.19 | |
| Biontech Se Sponsored Ads (BNTX) | 0.2 | $546k | 2.0k | 273.00 | |
| Codex Dna | 0.1 | $390k | 35k | 11.14 | |
| Provention Bio | 0.1 | $320k | 50k | 6.40 |
